Trial · NCT01650558
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Infections | Infections and infestations | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 414 | 500 | |
| other | Infections | Infections and infestations | Chloroquine (CQ) Prophylaxis | 428 | 500 | |
| other | Infections | Infections and infestations | Discontinuation of Standard of Care (Control Arm) | 443 | 499 | |
| other | General | General disorders | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 304 | 500 | |
| other | General | General disorders | Chloroquine (CQ) Prophylaxis | 267 | 500 | |
| other | General | General disorders | Discontinuation of Standard of Care (Control Arm) | 312 | 499 | |
| other | Investigations | Investigations | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 298 | 500 | |
| other | Investigations | Investigations | Chloroquine (CQ) Prophylaxis | 307 | 500 | |
| other | Investigations | Investigations | Discontinuation of Standard of Care (Control Arm) | 278 | 499 | |
| other | Gastrointestinal | Gastrointestinal disorders | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 248 | 500 | |
| other | Gastrointestinal | Gastrointestinal disorders | Chloroquine (CQ) Prophylaxis | 243 | 500 | |
| other | Gastrointestinal | Gastrointestinal disorders | Discontinuation of Standard of Care (Control Arm) | 291 | 499 | |
| other | Musculoskeletal | Musculoskeletal and connective tissue disorders | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 256 | 500 | |
| other | Musculoskeletal | Musculoskeletal and connective tissue disorders | Chloroquine (CQ) Prophylaxis | 223 | 500 | |
| other | Musculoskeletal | Musculoskeletal and connective tissue disorders | Discontinuation of Standard of Care (Control Arm) | 264 | 499 | |
| other | Blood | Blood and lymphatic system disorders | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 240 | 500 | |
| other | Blood | Blood and lymphatic system disorders | Chloroquine (CQ) Prophylaxis | 222 | 500 | |
| other | Blood | Blood and lymphatic system disorders | Discontinuation of Standard of Care (Control Arm) | 205 | 499 | |
| other | Nervous | Nervous system disorders | Standard of Care Trimethoprim Sulfamethoxazo (TS) Prophylaxis | 217 | 500 | |
| other | Nervous | Nervous system disorders | Chloroquine (CQ) Prophylaxis | 209 | 500 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01650558/events